Last reviewed · How we verify
hyperlipidemia
Approved treatments
- Niaspan · Medpointe Pharm Hlc
- Ezetrol · NVP Healthcare
- Niaspan · Cedars-Sinai Medical Center
- Unithroid · Fresenius Kabi
Unithroid works by replacing or supplementing the thyroid hormone thyroxine, which is produced by the thyroid gland. - Colestimide · Tanabe Pharma Corporation
Colestimide works by inhibiting the absorption of cholesterol and/or phosphorus in the intestines. - Choloxin · AbbVie
- Cholexamin
Cholexamin works by inhibiting the enzyme responsible for cholesterol synthesis. - Colestid · Pfizer
- Zetia · Merck & Co.
Zetia works by blocking the absorption of cholesterol in the small intestine. - Lorelco
- levothyroxin · Ain Shams University
- Thyroxine · Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Vascepa · University of Louisville
- Dextran 2-(Diethylamino)Ethyl Ether
Colextran works by binding to and removing excess cholesterol from the bloodstream. - Questran Light · Bristol Myers
- Synthroid · Generic (originally multiple — AbbVie/Synthroid)
Synthetic thyroxine (T4) that replaces deficient thyroid hormone, restoring normal metabolism, growth, and development. - Nicotinic Acid · MEDPOINTE PHARM HLC
- Pyridylcarbinol
Pyridylcarbinol works by providing the body with a precursor to NAD+, a crucial coenzyme involved in energy metabolism. - Tricor (Micronized) · Salix
Fenofibrate activates PPARα, enhancing lipolysis and reducing triglycerides, while increasing HDL-cholesterol and uric acid excretion. - Lipavil
- olmesartan medoxomil-hydrochlorothiazide · Cosette
Olmesartan works by blocking the action of a hormone that causes blood vessels to constrict, allowing blood vessels to relax and blood pressure to decrease. - Befizal
- Lisinopril/HCTZ · Direct_Rx
- Vascepa · Amarin Pharms
- Trilipix · AbbVie
- Tryvio · Idorsia
Tryvio works by blocking the action of endothelin, a protein that constricts blood vessels and increases blood pressure. - Mevacor · Merck & Co.
Mevacor works by inhibiting the enzyme HMG-CoA reductase, which plays a key role in cholesterol production in the liver.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- hyperlipidemia patent landscape — cliff calendar, originator estates, attackable patents
- hyperlipidemia treatment landscape brief
- hyperlipidemia treatment updates RSS
Frequently asked questions about hyperlipidemia
What drugs treat hyperlipidemia?
Tracked treatments include Niaspan, Ezetrol, Unithroid, Colestimide, Choloxin, Cholexamin, Colestid, Zetia.
What is the treatment for hyperlipidemia?
Standard treatment for hyperlipidemia includes Niaspan, Ezetrol, Unithroid, Colestimide, Choloxin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: hyperlipidemia patent cliff · hyperlipidemia CI report
- Treatment: Niaspan · Medpointe Pharm Hlc
- Treatment: Ezetrol · NVP Healthcare
- Treatment: Niaspan · Cedars-Sinai Medical Center
- Treatment: Unithroid · Fresenius Kabi
- Treatment: Colestimide · Tanabe Pharma Corporation
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing